{
    "type": "VariantTherapeuticResponseProposition",
    "predicate": "sensitivity",
    "description": "Pediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy",
    "geneContextQualifier": "BCR | ABL1",
    "objectTherapeutic": "Imatinib Mesylate [Gleevec] &"
}